3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
13
Breast
5
Thoracic
3
Genitourinary
3
Sarcoma
2
Head & Neck
2
Gastrointestinal
2
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Dermatologic
1
CNS
1
Conditions
Advanced Solid Tumors
40
Advanced Solid Tumor
24
Solid Tumors
23
Mesothelioma, Malignant
14
Mesothelioma
14
Solid Tumor
12
Hematopoietic and Lymphatic System Neoplasm
12
Ovarian Neoplasms
8
Malignant Solid Neoplasm
7
Pancreatic Neoplasms
6
Solid Tumours
5
Solid Tumor, Adult
5
Neoplasms
5
Colorectal Neoplasms
5
Stomach Neoplasms
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Advanced Solid Tumour
4
Triple Negative Breast Neoplasms
3
Sarcoma
3
Retinoblastoma
3
Kidney Neoplasms
3
Advanced or Metastatic Solid Tumors
3
Advanced Malignant Solid Tumors
3
Advanced Malignant Solid Neoplasm
3
Thymoma
2
Solitary Fibrous Tumor, Pleural
2
Solid Tumor Malignancies
2
Solid Tumor Cancer
2
Small Cell Lung Carcinoma
2
Interventions
pembrolizumab
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Other solid neoplasm
×
30 days
×
Clear all
NCT05579366
2026-06-03
RAINFOL-01
Genmab
Phase 1/2
Recruiting
884 enrolled